PROFUSA, INC. Share-based Payment Arrangement, Expense
PROFUSA, INC. (PFSA) reported Share-based Payment Arrangement, Expense of $188.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-19
- PROFUSA, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $188.00K, a 129.27% increase year-over-year.
- PROFUSA, INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $187.00K, a 3640.00% increase year-over-year.
- PROFUSA, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $187.00K, a 3640.00% increase year-over-year.
- PROFUSA, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $617.00K, a 5041.67% increase year-over-year.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $188.00K 10-Q · filed 2026-08-19 | $375.00K 10-Q · filed 2026-08-19 | $562.00K derived: sum of 3 quarters · filed 2026-08-19 | $1.18M derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $187.00K 10-Q · filed 2026-05-15 | $374.00K derived: sum of 2 quarters · filed 2026-05-15 | $991.00K derived: sum of 3 quarters · filed 2026-05-15 | $1.07M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $187.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $804.00K derived: sum of 2 quarters · filed 2026-05-01 | $886.00K derived: sum of 3 quarters · filed 2026-08-19 | $891.00K S-1/A · filed 2026-05-01 |
| 2025-09-30 | $617.00K 10-Q · filed 2025-11-19 | $699.00K derived: sum of 2 quarters · filed 2026-08-19 | $704.00K 10-Q · filed 2025-11-19 | $709.00K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $82.00K 10-Q · filed 2026-08-19 | $87.00K 10-Q · filed 2026-08-19 | $92.00K derived: sum of 3 quarters · filed 2026-08-19 | $104.00K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $5.00K 10-Q · filed 2026-05-15 | $10.00K derived: sum of 2 quarters · filed 2026-05-15 | $22.00K derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | $5.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $17.00K derived: sum of 2 quarters · filed 2026-05-01 | $21.00K S-1/A · filed 2026-05-01 | |
| 2024-09-30 | $12.00K 10-Q · filed 2025-11-19 | $16.00K 10-Q · filed 2025-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |